Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
National Institutes of Health Clinical Center (CC)
With
OBJECTIVE: The primary objective of this study is to evaluate the NeuroDRIVE behavioral intervention for enhancement of driving abilities, cognitive abilities, and neurobehavioral symptoms after traumatic brain injury (TBI). For the purposes of this protocol, NeuroDRIVE refers to the novel combined approach of driving training and cognitive rehabilitation in a virtual reality environment. While NeuroDRIVE utilizes the VR system as the method through which the intervention is administered, NeuroDRIVE is not the VR system itself. STUDY POPULATION: 30 adult patients with a history of mild TBI and 30 adult patients with a history of moderate-to-severe TBI. Participants will be recruited from the National Institutes of Health (NIH), WRNMMC, and the broader community. DESIGN: The current study is a Clinical Trial Phase II interventional research study. The primary purpose of the study is for treatment, and it will employ a parallel intervention model. There will be no masking (i.e., open label). Participants will be classified into two groups by TBI severity: those with history of mild TBI and those with history of moderate-tosevere TBI. These different severities are known to have distinct cognitive sequelae. Within each severity group, participants will be in a 2 (pre-post) x 2 (treatment vs. wait list) experimental design. OUTCOME MEASURES: Primary outcome measures will include: * Results from the Virtual Reality Driving Assessment (baseline and postintervention Tactical scenario composite scores) * Total scores on the Neurobehavioral Symptom Inventory * Standard and scaled scores from the following cognitive assessments (from the TBI Common Data Elements identified by NINDS): WAIS-IV or WMS-IV Digit Span subtest WAIS-IV Digit-Symbol Coding subtest Secondary outcome measures will include: -Neuroimaging results: Regions of Interest for FMRI: Bilateral dorsolateral prefrontal cortex Regions of Interest for DTI: Corpus callosum, bilateral frontal white matter horns, and bilateral longitudinal fasciculi -Total scores on the following symptom questionnaires: Glasgow Outcome Scale-Extended (GOS-E) Ohio State University TBI Identification Method Brief Symptom Inventory- 18 Satisfaction with Life Scale (SWLS) PTSD Checklist- Civilian (PCL-C) SF-36v2 Health Survey (SF-36v2) Fatigue Severity Scale (FSS) Epworth Sleepiness Scale (ESS) Beck Depression Inventory-II (BDI-II) Combat Exposure Scale (CES) Dual Dangerous Driving Index (DDDI) -Standard and scaled scores from the following cognitive phenotyping assessments (from the TBI Common Data Elements identified by NINDS): California Verbal Learning Test- Second Edition (CVLT-II) WAIS-IV Symbol Search subtest Medical Symptom Validity Test (MSVT) -Standard and scaled scores from the following additional cognitive phenotyping assessments: Trail Making Test (TMT) Test of Premorbid Functioning (ToPF) Grooved Pegboard Controlled Oral Word Association Test (COWAT) Bethesda Eye and Attention Measure (BEAM)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
